E-ISSN: 1309-0380
    Effect of GnRH analogues and octreotide treatment on apoptosis and the cell proliferation of endometrium adenocarcinoma cell lines
    PDF
    Cite
    Share
    Request
    Original Investigation
    VOLUME: 11 ISSUE: 3
    P: 131-136
    September 2010

    Effect of GnRH analogues and octreotide treatment on apoptosis and the cell proliferation of endometrium adenocarcinoma cell lines

    J Turk Ger Gynecol Assoc 2010;11(3):131-136
    DOI: 10.5152/jtgga.2010.19
    Harika Bodur Öztürk 1
    Birol Vural 2
    Eray Çalışkan 3
    Seyhun Solakoğlu 4
    1. Department Of Obstetrics And Gynecology, Acibadem University, Istanbul, Turkey
    2. Department Of Obstetric And Gynecology, School Of Medicine, Kocaeli University, Kocaeli, Turkey
    3. Department Of Obstetrics And Gynecology, Faculty Of Medicine, Kocaeli University, Kocaeli, Turkey
    4. Department Of Histology And Embryology, School Of Medicine, Istanbul University, Istanbul, Turkey
    No information available.
    No information available
    Received Date: 01.07.2010
    Accepted Date: 12.08.2010
    PDF
    Cite
    Share
    Request

    ABSTRACT

    Objective:

    The aim of this study was to compare apoptotic and antiproliferative effects of gonadotropin-releasing hormone analogues and their combination with octeotide on endometrioid endometrial cancer cell lines.

    Material and Method:

    Women diagnosed with endometrioid adenocarcinoma at the department of Gynecology and Obstetric of Kocaeli University Medical School were included in this research. Endometrium cancer cell lines obtained from three patients were used for this study. After trypsinization in 0.5% in calcium magnesium, free phosphate buffer solution (CMFPBS) cells were seeded on glass slides in 24-well plates containing DMEM-F12 medium and 10% fetal calf serum as culture medium. Cells were incubated for 24 hours at 37ºC in 5% CO2. GnRH agonist leuprolide (Lucrin 1 µmol/L), GnRH antagonist ganirelix (Orgalutran 1 µmol/L), leuprolide with octreotide (Sandostatin 10-6 mol/L), ganirelix with octreotide and no drug were added to the wells. Apoptosis and cells proliferations were evaluated after 12, 24, 48 and 72th hours of incubation. The percentage of apoptotic cells was evaluated by TdT mediated biotin-dUTP nick-end labeling (TUNEL) method; cell proliferation was assessed by bromodeoxyuridine (BrdU) incorporation.

    Results:

    Apoptotic index in grade I EEC cell line among ganirelix-octreotide treated cells and leuprolide-octreotide combination therapy were respectively higher than the untreated control (p<0.001, p=0.001). The number of apoptotic cells in grade II EEC cell line among leuprolide-octreotide and leuprolide were significantly (p<0.001, p<0.001) higher than in controls. In grade III EEC cell line, the number of TUNEL positive cells among leuprolide, ganirelix and ganirelix-octreotide therapiy groups were significantly higher than in untreated control. Time dependent antiproliferative effect was obtained with leuprolide and leuprolide-octreotide in grade I EEC (p<0.001, p<0.001). Grade II EEC cell line is not influenced by hormonotherapies. However, the antiproliferative effect was obtained with ganirelix, leuprolide and leuprolide-octreotide in grade III cell line.

    Conclusion:

    GnRH analogues appears to have a direct effect, enhancing the apoptotic index and decreasing the cell proliferation in endometrial adenocancer cell lines.

    Keywords: Endometrial cancer, gonadotropin-releasing hormone analogues, octreotide, apoptosis, cell proliferation

    References

    2024 ©️ Galenos Publishing House